These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30050299)

  • 1. Bioengineering the spider silk sequence to modify its affinity for drugs.
    Kucharczyk K; Weiss M; Jastrzebska K; Luczak M; Ptak A; Kozak M; Mackiewicz A; Dams-Kozlowska H
    Int J Nanomedicine; 2018; 13():4247-4261. PubMed ID: 30050299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of chemotherapeutics using spheres made of bioengineered spider silks derived from MaSp1 and MaSp2 proteins.
    Jastrzebska K; Florczak A; Kucharczyk K; Lin Y; Wang Q; Mackiewicz A; Kaplan DL; Dams-Kozlowska H
    Nanomedicine (Lond); 2018 Feb; 13(4):439-454. PubMed ID: 29338625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications.
    Kucharczyk K; Rybka JD; Hilgendorff M; Krupinski M; Slachcinski M; Mackiewicz A; Giersig M; Dams-Kozlowska H
    PLoS One; 2019; 14(7):e0219790. PubMed ID: 31306458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The method of purifying bioengineered spider silk determines the silk sphere properties.
    Jastrzebska K; Felcyn E; Kozak M; Szybowicz M; Buchwald T; Pietralik Z; Jesionowski T; Mackiewicz A; Dams-Kozlowska H
    Sci Rep; 2016 Jun; 6():28106. PubMed ID: 27312998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells.
    Kucharczyk K; Florczak A; Deptuch T; Penderecka K; Jastrzebska K; Mackiewicz A; Dams-Kozlowska H
    J Nanobiotechnology; 2020 Mar; 18(1):56. PubMed ID: 32228620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and cytotoxicity of tag-free bioengineered spider silk proteins.
    Dams-Kozlowska H; Majer A; Tomasiewicz P; Lozinska J; Kaplan DL; Mackiewicz A
    J Biomed Mater Res A; 2013 Feb; 101(2):456-64. PubMed ID: 22865581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalized spider silk spheres as drug carriers for targeted cancer therapy.
    Florczak A; Mackiewicz A; Dams-Kozlowska H
    Biomacromolecules; 2014 Aug; 15(8):2971-81. PubMed ID: 24963985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.
    Kozlowska AK; Florczak A; Smialek M; Dondajewska E; Mackiewicz A; Kortylewski M; Dams-Kozlowska H
    Acta Biomater; 2017 Sep; 59():221-233. PubMed ID: 28694238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMPs-responsive silk spheres for controlled drug release within tumor microenvironment.
    Kucharczyk K; Florczak A; Kaminska A; Guzniczak N; Sikorska A; Deptuch T; Dams-Kozlowska H
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):132016. PubMed ID: 38697442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics.
    Florczak A; Jastrzebska K; Bialas W; Mackiewicz A; Dams-Kozlowska H
    J Biomed Mater Res A; 2018 Dec; 106(12):3211-3221. PubMed ID: 30242958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blending two bioengineered spider silks to develop cancer targeting spheres.
    Florczak A; Jastrzebska K; Mackiewicz A; Dams-Kozlowska H
    J Mater Chem B; 2017 Apr; 5(16):3000-3011. PubMed ID: 32263992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres.
    Florczak A; Mackiewicz A; Dams-Kozlowska H
    Int J Nanomedicine; 2019; 14():6855-6865. PubMed ID: 32021156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo.
    Florczak A; Deptuch T; Lewandowska A; Penderecka K; Kramer E; Marszalek A; Mackiewicz A; Dams-Kozlowska H
    J Nanobiotechnology; 2020 Dec; 18(1):177. PubMed ID: 33261651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres.
    Kucharczyk K; Kaczmarek K; Jozefczak A; Slachcinski M; Mackiewicz A; Dams-Kozlowska H
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111654. PubMed ID: 33545822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo study of the immune response to bioengineered spider silk spheres.
    Deptuch T; Penderecka K; Kaczmarek M; Molenda S; Dams-Kozlowska H
    Sci Rep; 2022 Aug; 12(1):13480. PubMed ID: 35931709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailor-made spider-eggcase-silk spheres for efficient lysosomal drug delivery.
    Chen J; Hu J; Zuo P; Su X; Liu Z; Yang M
    RSC Adv; 2018 Feb; 8(17):9394-9401. PubMed ID: 35541844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular uptake of drug loaded spider silk particles.
    Schierling MB; Doblhofer E; Scheibel T
    Biomater Sci; 2016 Sep; 4(10):1515-1523. PubMed ID: 27709129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment.
    Yavuz B; Zeki J; Coburn JM; Ikegaki N; Levitin D; Kaplan DL; Chiu B
    J Control Release; 2018 Sep; 285():162-171. PubMed ID: 30018030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.
    Nittayacharn P; Nasongkla N
    J Mater Sci Mater Med; 2017 Jul; 28(7):101. PubMed ID: 28534285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioengineering of spider silks for the production of biomedical materials.
    Bittencourt DMC; Oliveira P; Michalczechen-Lacerda VA; Rosinha GMS; Jones JA; Rech EL
    Front Bioeng Biotechnol; 2022; 10():958486. PubMed ID: 36017345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.